Detalhe da pesquisa
1.
Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
BMC Microbiol
; 16(1): 165, 2016 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27464881
2.
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Vaccine
; 40(32): 4412-4423, 2022 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680500
3.
Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates.
Cell Host Microbe
; 30(1): 41-52.e5, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34879230
4.
Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase.
Bioorg Med Chem Lett
; 21(24): 7344-50, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22071300
5.
Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors.
Bioorg Med Chem Lett
; 20(14): 4065-8, 2010 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20547452
6.
Biaryl ethers as potent allosteric inhibitors of reverse transcriptase and its key mutant viruses: aryl substituted pyrazole as a surrogate for the pyrazolopyridine motif.
Bioorg Med Chem Lett
; 20(15): 4328-32, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20609585
7.
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
NPJ Vaccines
; 5(1): 16, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128257
8.
Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor.
Antimicrob Agents Chemother
; 53(6): 2424-31, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289522
9.
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.
Bioorg Med Chem Lett
; 19(17): 5119-23, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19631528
10.
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein.
Nat Commun
; 10(1): 4153, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515478
11.
Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
Vaccine
; 36(52): 8119-8130, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30340881
12.
A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
Vaccine
; 36(20): 2876-2885, 2018 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599087
13.
Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
PLoS One
; 12(11): e0187642, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29121080
14.
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses.
J Med Chem
; 52(22): 7163-9, 2009 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19883100
15.
Strategies towards improving the pharmacokinetic profile of ε-substituted lysinol-derived HIV protease inhibitors.
ChemMedChem
; 6(2): 253-7, 2011 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21275047